Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCHAL.L Regulatory News (CHAL)

  • There is currently no data for CHAL

Lapse to Extended Longstop Date

1 Mar 2021 15:00

RNS Number : 7462Q
Challenger Acquisitions Limited
01 March 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY,

WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

 

 

For immediate release 01 March 2021

 

Challenger Acquisitions Limited

('Challenger' or the 'Company')

 

Offer for Cindrigo Limited - Lapse to Extended Longstop Date

 

Challenger Acquisitions Limited (LSE: CHAL) announces that following discussions with Cindrigo Energy Limited ('CEL') and Cindrigo Limited (together 'Cindrigo') the Offer made to certain shareholders of CEL has lapsed on the extended Longstop Date of 26th February 2021. The Offer was made to certain shareholders of CEL, on 31 August 2020 (the 'Offer'), for the shares in Cindrigo Limited that CEL shareholders would have acquired pursuant to a Plan of Arrangement ('PoA'), relating to CEL pursuant to the laws of British Columbia, Canada. Cindrigo is part of a group of companies pursuing renewable energy projects built on broad Swedish expertise and experience in the waste to energy and biomass energy sector (see www.cindrigo.com).

 

The Boards of Challenger and Cindrigo are investigating an alternative transaction structure to achieve the proposed reverse takeover of the Cindrigo business by Challenger on potentially improved commercial terms. The alternative structure will require approval from the shareholders of both companies and both the Company and CEL anticipate convening meetings of their respective shareholders in due course to seek the required approvals for such alternative transaction. The Company will make a further announcement relating to a proposed new transaction when appropriate.

 

Notwithstanding the lapse of the Offer, as a reverse takeover of Cindrigo is still in contemplation, the Company has not requested the Financial Conduct Authority to end the suspension of Challenger's listing pursuant to Listing Rule 5.4.3 and the Company expects the suspension to continue until the completion of a reverse takeover.

 

Lars Guldstrand, Challenger's CEO, said, "Despite the lapse of the Offer both Challenger and Cindrigo remain committed to the acquisition of the business of Cindrigo Limited by Challenger (the 'Acquisition') and we will continue to work together to agree a satisfactory commercial arrangement is reached for both parties."

 

**ENDS**

 

For more information visit www.challengeracquisitions.com or enquire to:

 

St Brides Partners Ltd (PR)

Frank Buhagiar / Cosima Akerman

+44 (0) 20 7236 1177

 

Challenger Acquisitions Ltd

Jorgen Andersson

 

Cindrigo Limited

 

 

+46 (0) 76 871 6373

Mustaq Patel

+44 (0) 7408 886 668

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEALDFESDFEFA
Date   Source Headline
17th May 20167:00 amRNSResult of AGM
16th May 20167:00 amRNSPurchase of Shares by Director
9th May 20167:00 amRNSPurchase of Shares by Director
3rd May 20167:00 amRNSPurchase of Shares by Director
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 20164:50 pmRNSAnnual Report and Notice of AGM
27th Apr 20167:00 amRNSFinal Results
26th Apr 20167:00 amRNSConvertible Notes Extension & Issue of £0.5m Note
13th Apr 20162:00 pmRNSAllotment of Shares re Convertible Loan Notes
31st Mar 20167:00 amRNSUpdate on Global Giant Observation Wheel Activity
24th Mar 20165:48 pmRNSFurther Re: Conversion of Convertible Loan Notes
21st Mar 20167:00 amRNSConversion of Convertible Loan Notes
9th Mar 201612:35 pmRNSPresenting at Shares Investor Evening
3rd Mar 20167:00 amRNSIssue of £0.5m convertible notes
22nd Feb 20167:00 amRNSUpdate on Giant Observation Wheel in Jakarta
5th Feb 20167:00 amRNSHolding(s) in Company
29th Jan 20165:00 pmRNSTotal Voting Rights
29th Jan 20167:00 amRNSIncreases Investment in New York Wheel
15th Jan 20167:00 amRNSAppointment of Financial Adviser
12th Jan 20167:00 amRNSAppointment of New Directors
7th Jan 20163:51 pmRNSAllotment of Shares and Options Granted
8th Dec 20158:00 amRNSReadmission to trading on London Stock Exchange
8th Dec 20158:00 amRNSCancellation - Challenger Acquisitions Limited
2nd Dec 20152:11 pmRNSPublication of Prospectus & Expected Readmission
30th Oct 201511:52 amRNSTotal Voting Rights
10th Sep 20155:30 pmRNSGrant of Options and Prospectus Update
28th Aug 20153:33 pmRNSHalf Yearly Report
5th Aug 201512:42 pmRNSHolding(s) in Company
30th Jul 20152:55 pmRNSFunding update, grant of options & issue of equity
21st Jul 20151:14 pmRNSHolding(s) in Company
16th Jul 20158:00 amRNSAcquisition of Starneth Completed
7th Jul 201512:34 pmRNSIssue of Equity
27th May 20153:31 pmRNSHolding(s) in Company
26th May 20159:25 amRNSInvestment, LOI and suspension
26th May 20159:10 amRNSSuspension Challenger Acquisitions Limited
20th May 20157:00 amRNSFunding Update
13th May 20155:23 pmRNSHolding(s) in Company
28th Apr 20158:00 amRNSProposed funding: up to £3m via convertible notes
7th Apr 201510:10 amRNSUK Investor Show
2nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20154:35 pmRNSPrice Monitoring Extension
18th Mar 20158:00 amRNSCorporation Agreement with Starneth signed
19th Feb 20157:00 amRNSAdmission to Trading and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.